Infection Control Business Unit Reaches Key Struc-tural Milestones

The spin-off of the new Life Science Solutions Business Unit marks the completion of an important phase of restructuring for the Infection Control Busi-ness Unit. Beat Spalinger, current CEO of the Infection Control Business Unit, is stepping down from operational management. Dominik Arnold has been appointed as new CEO of the Infection Control Business Unit.

>> Press release

Locate a Sales or Service Representative